Drugs of abuse public hearing
This article was originally published in The Gray Sheet
Executive Summary
Input on a March 5 proposed rule to downclassify from Class III to Class I over-the-counter urine sample collection systems for drugs-of-abuse testing will be sought at a June 19 meeting in Rockville, Maryland. William Schultz, FDA deputy commissioner for policy, will direct the meeting. For more information contact the device center's Steven Gutman at 301/594-3084